I tend to agree with you that $9.5 appears to be support for the stock.  Lets see if this is true over the next few days.  INFN had a so-so quarter.  It met on the bottom line and slightly exceeded on the top line.

The disappointment was on guidance, specifically the fact that it will not start growing revenues until the second half.

However, I truly believe that the company will grow revenues quite well in 2018. The product road map is now on a solid path and it will be predictable, something it has not been able to do in the past.

I believe it's stock price can do quite well over the next two years.